International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases – Markets Insider
DailyCommerceNews |
International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases
Markets Insider CARLSBAD, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company that develops novel stem … International Stem Cell Corporation announces breakthrough with 3D bioprinted liver tissue US Stem Cell Inc (OTCMKTS:USRM) Could Be A Nice Recovery Play Stem Cell Assay Market is Expected to Reach USD $1364 Million by 2021 |
